Orchid Pharma has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, Enmetazobactam'. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (EMA).
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.